IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD

BACKGROUND AND OBJECTIVES: Systemic inflammation modulates cardiovascular disease risk and functionality of HDL in the setting of CKD. Whether interventions that modify systemic inflammation can improve HDL function in CKD is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin J Am Soc Nephrol
Autori principali: Hung, Adriana M., Tsuchida, Yohei, Nowak, Kristen L., Sarkar, Sudipa, Chonchol, Michel, Whitfield, Victoria, Salas, Natjalie, Dikalova, Anna, Yancey, Patricia G., Huang, Jiansheng, Linton, MacRae F., Ikizler, T. Alp, Kon, Valentina
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Nephrology 2019
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500942/
https://ncbi.nlm.nih.gov/pubmed/31015261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.04360418
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi